BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25269722)

  • 1. Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia.
    Park HJ; Kim JW; Song KH; Seo KW
    J Vet Sci; 2015; 16(1):127-30. PubMed ID: 25269722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded platelets.
    Weigert O; Wittmann G; Gruetzner S; Cnossen J; Becker MC; Dreyling M; Ostermann H
    Thromb Haemost; 2008 Oct; 100(4):705-7. PubMed ID: 18841296
    [No Abstract]   [Full Text] [Related]  

  • 3. Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures.
    Shvidel L; Sigler E; Shtalrid M; Berrebi A
    Am J Hematol; 2006 Jun; 81(6):423-5. PubMed ID: 16680744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of therapeutic plasma exchange in dogs with immune-mediated thrombocytopenia.
    Kopecny L; Palm CA; Naylor S; Kirby J; Cowgill LD
    J Vet Intern Med; 2020 Jul; 34(4):1576-1581. PubMed ID: 32557826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC
    J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine-loaded platelet therapy for idiopathic thrombocytopenia in a dog.
    Helfand SC; Jain NC; Paul M
    J Am Vet Med Assoc; 1984 Jul; 185(2):224-6. PubMed ID: 6746398
    [No Abstract]   [Full Text] [Related]  

  • 7. Canine idiopathic thrombocytopenic purpura.
    Lewis DC; Meyers KM
    J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs.
    Rozanski EA; Callan MB; Hughes D; Sanders N; Giger U
    J Am Vet Med Assoc; 2002 Feb; 220(4):477-81. PubMed ID: 11860242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine-loaded platelets for immune thrombocytopenia.
    Weigert O; Wittmann G; Grützner S; Christ O; Christ B; Rank A; Ostermann H
    Thromb Haemost; 2010 Aug; 104(2):418-9. PubMed ID: 20508905
    [No Abstract]   [Full Text] [Related]  

  • 12. Presumptive immune-mediated thrombocytopenia secondary to massive Africanized bee envenomation in a dog.
    Nakamura RK; Fenty RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2013; 23(6):652-6. PubMed ID: 24304842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: a pilot study.
    O'Marra SK; Shaw SP; deLaforcade AM
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):126-30. PubMed ID: 22316313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs.
    Davidow EB; Brainard B; Martin LG; Beal MW; Bode A; Ford MJ; Ramsey N; Fagella A; Jutkowitz A
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):116-25. PubMed ID: 23016747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients.
    Stirnemann J; Kaddouri N; Khellaf M; Morin AS; Prendki V; Michel M; Mekinian A; Bierling P; Fenaux P; Godeau B; Fain O
    Eur J Haematol; 2016 Mar; 96(3):269-75. PubMed ID: 25976731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet volume and plateletcrit in dogs with presumed primary immune-mediated thrombocytopenia.
    Schwartz D; Sharkey L; Armstrong PJ; Knudson C; Kelley J
    J Vet Intern Med; 2014; 28(5):1575-9. PubMed ID: 25056453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine pemphigus foliaceus with concurrent immune-mediated thrombocytopenia.
    Kawarai S; Hisasue M; Matsuura S; Ito T; Inoue Y; Neo S; Fujii Y; Madarame H; Shirota K; Tsuchiya R
    J Am Anim Hosp Assoc; 2015; 51(1):56-63. PubMed ID: 25415212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine therapy for mast cell tumors in dogs.
    McCaw DL; Miller MA; Bergman PJ; Withrow SJ; Moore AS; Knapp DW; Fowler D; Johnson JC
    J Vet Intern Med; 1997; 11(6):375-8. PubMed ID: 9470165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006).
    Dircks BH; Schuberth HJ; Mischke R
    J Am Vet Med Assoc; 2009 Oct; 235(8):960-6. PubMed ID: 19827982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of vincristine in splenectomized patients with refractory or relapsed immune thrombocytopenia: a retrospective single-center study.
    Park YH; Yi HG; Lee MH; Kim CS; Lim JH
    Int J Hematol; 2016 Feb; 103(2):180-8. PubMed ID: 26588926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.